GALMED PHARMACEUTICALS LTD. Capital Expenditures
GALMED PHARMACEUTICALS LTD. (GLMD) reported Capital Expenditures of $4.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-04-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-04-02
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|
| 2022-12-31 | $4.00K 20-F · filed 2025-04-02 | |
| 2022-06-30 | $3.00K 6-K · filed 2023-08-09 | |
| 2021-12-31 | $11.00K 20-F · filed 2024-04-04 | |
| 2021-06-30 | $8.00K 6-K · filed 2022-08-04 | |
| 2020-12-31 | $44.00K 20-F · filed 2023-03-29 | |
| 2020-06-30 | $5.00K 6-K · filed 2021-08-05 | |
| 2019-12-31 | $12.00K 20-F · filed 2022-05-02 | |
| 2019-06-30 | $4.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $90.00K 20-F · filed 2021-03-18 | |
| 2018-06-30 | $1.00K 6-K · filed 2019-08-05 | |
| 2017-12-31 | $12.00K 20-F · filed 2020-03-12 | |
| 2017-06-30 | $8.00K 6-K · filed 2018-08-02 | |
| 2016-12-31 | $17.00K 20-F · filed 2019-03-13 | |
| 2016-06-30 | $23.00K 6-K · filed 2017-07-31 | |
| 2015-12-31 | $159.00K 20-F · filed 2018-03-13 | |
| 2015-06-30 | $154.00K 6-K · filed 2017-06-23 | |
| 2014-12-31 | $770.00K 20-F · filed 2017-03-23 | |
| 2013-12-31 | $13.00K 20-F · filed 2016-03-22 | |
| 2012-12-31 | $32.00K 20-F · filed 2015-03-31 |